WNT Signaling Pathway Gene Polymorphisms and Risk of Hepatic Fibrosis and Inflammation in HCV-Infected Patients

• Yanhong Liu,

  Affiliations Department of Pediatrics, Baylor College of Medicine, Houston, Texas, United States of America, Dan L. Duncan Cancer Center at Baylor College of Medicine, Houston, Texas, United States of America

  ⨯
• Hashem B. El-Serag,

  Affiliations Section of Gastroenterology and Hepatology, Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston, Texas, United States of America, Clinical Epidemiology and Comparative Effectiveness Program, Section of Health Services Research (IQuEST), Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston, Texas, United States of America, Dan L. Duncan Cancer Center at Baylor College of Medicine, Houston, Texas, United States of America, Texas Medical Center Digestive Disease Center, Houston, Texas, United States of America

  ⨯
• Li Jiao,

  Affiliations Section of Gastroenterology and Hepatology, Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston, Texas, United States of America, Clinical Epidemiology and Comparative Effectiveness Program, Section of Health Services Research (IQuEST), Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston, Texas, United States of America, Dan L. Duncan Cancer Center at Baylor College of Medicine, Houston, Texas, United States of America, Texas Medical Center Digestive Disease Center, Houston, Texas, United States of America, Center for Translational Research on Inflammatory Diseases (CTRID), Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, United States of America

  ⨯
• JuSeog Lee,

  Affiliation Department of Systems Biology, MD Anderson Cancer Center, Houston, Texas, United States of America

  ⨯
• David Moore,

  Affiliation Department Molecular and Cell Biology and Department of Medicine, Baylor College of Medicine, Houston, Texas, United States of America

  ⨯
• Luis M. Franco,

  Affiliation Department of Molecular and Human Genetics, Baylor College of Medicine, Houston, Texas, United States of America

  ⨯
• Shahriar Tavakoli-Tabasi,

  Affiliation Section of Infectious Diseases, Michael E. DeBakey Veterans Affairs Medical Center and Baylor College of Medicine, Houston, Texas, United States of America

  ⨯
• Spiridon Tsavachidis,

  Affiliation Dan L. Duncan Cancer Center at Baylor College of Medicine, Houston, Texas, United States of America

  ⨯
• Jill Kuzniarek,

  Affiliation Clinical Epidemiology and Comparative Effectiveness Program, Section of Health Services Research (IQuEST), Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston, Texas, United States of America

  ⨯
• David J. Ramsey,

  Affiliation Clinical Epidemiology and Comparative Effectiveness Program, Section of Health Services Research (IQuEST), Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston, Texas, United States of America

  ⨯
• Donna L. White

  * E-mail: dwhite1@bcm.edu

  Affiliations Section of Gastroenterology and Hepatology, Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston, Texas, United States of America, Clinical Epidemiology and Comparative Effectiveness Program, Section of Health Services Research (IQuEST), Michael E. DeBakey VA Medical Center and Baylor College of Medicine, Houston, Texas, United States of America, Dan L. Duncan Cancer Center at Baylor College of Medicine, Houston, Texas, United States of America, Texas Medical Center Digestive Disease Center, Houston, Texas, United States of America, Center for Translational Research on Inflammatory Diseases (CTRID), Michael E. DeBakey Veterans Affairs Medical Center, Houston, Texas, United States of America

  ⨯